Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2010, Article ID 354645, 10 pages
http://dx.doi.org/10.1155/2010/354645
Review Article

Endothelin-1 Role in Human Eye: A Review

Department of Ophthalmology, University “La Sapienza”, Polo Pontino, Latina, Italy

Received 14 June 2010; Revised 14 November 2010; Accepted 13 December 2010

Academic Editor: Alon Harris

Copyright © 2010 Serena Salvatore and Enzo Maria Vingolo. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Yanagisawa, H. Kurihara, S. Kimura et al., “A novel potent vasoconstrictor peptide produced by vascular endothelial cells,” Nature, vol. 332, no. 6163, pp. 411–415, 1988. View at Google Scholar · View at Scopus
  2. A. Giaid, S. J. Gibson, N. B. N. Ibrahim et al., “Endothelin 1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganGlia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 19, pp. 7634–7638, 1989. View at Google Scholar · View at Scopus
  3. R. M. Kedzierski and M. Yanagisawa, “Endothelin system: the double-edged sword in health and disease,” Annual Review of Pharmacology and Toxicology, vol. 41, pp. 851–876, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Yanagisawa, “The endothelin system: a new target for therapeutic intervention,” Circulation, vol. 89, no. 3, pp. 1320–1322, 1994. View at Google Scholar · View at Scopus
  5. A. Inoue, M. Yanagisawa, S. Kimura et al., “The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 8, pp. 2863–2867, 1989. View at Google Scholar · View at Scopus
  6. K. Takahashi, M. A. Ghatei, P. M. Jones et al., “Endothelin in human brain and pituitary gland: presence of immunoreactive endothelin, endothelin messenger ribonucleic acid, and endothelin receptors,” Journal of Clinical Endocrinology and Metabolism, vol. 72, no. 3, pp. 693–699, 1991. View at Google Scholar · View at Scopus
  7. T. Nishimura, J. Krier, and T. Akasu, “Endothelin causes prolonged inhibition of nicotinic transmission in feline colonic parasympathetic ganGlia,” American Journal of Physiology, vol. 261, no. 4, pp. G628–G633, 1991. View at Google Scholar · View at Scopus
  8. U. Chakravarthy, A. J. Douglas, J. R. Bailie, B. McKibben, and D. B. Archer, “Immunoreactive endothelin distribution in ocular tissues,” Investigative Ophthalmology and Visual Science, vol. 35, no. 5, pp. 2448–2454, 1994. View at Google Scholar · View at Scopus
  9. Y. Takashima, H. Takagi, M. Takahashi et al., “Endothelin protein expression in tear glands of the rabbit,” Current Eye Research, vol. 15, no. 7, pp. 768–773, 1996. View at Google Scholar · View at Scopus
  10. A. Lepple-Wienhues, M. Becker, F. Stah et al., “Endothelin-like immunoreactivity in the aqueous humour and in conditioned medium from cultured ciliary epithelial cells,” Current Eye Research, vol. 11, no. 11, pp. 1041–1046, 1992. View at Google Scholar · View at Scopus
  11. M. Murata, M. Nakagawa, and S. Takahashi, “Selective expression of endothelin 1 mRNA in rat retina,” Ophthalmologica, vol. 212, no. 5, pp. 331–333, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. R. F. Furchgott and J. V. Zawadzki, “The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine,” Nature, vol. 288, no. 5789, pp. 373–376, 1980. View at Google Scholar · View at Scopus
  13. T. F. Luscher and P. M. Vanhoutte, The Endothelium: Modulator of Cardiovascular Function, CRC Press, Boca Raton, Fla, USA, 1990.
  14. I. O. Haefliger, J. Flammer, and T. F. Luscher, “Nitric oxide and endothelin-1 are important regulators of human ophthalmic artery,” Investigative Ophthalmology and Visual Science, vol. 33, no. 7, pp. 2340–2343, 1992. View at Google Scholar · View at Scopus
  15. I. Saenz de Tejada, I. Goldstein, K. Azadzoi, R. J. Krane, and R. A. Cohen, “Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence,” The New England Journal of Medicine, vol. 320, no. 16, pp. 1025–1030, 1989. View at Google Scholar · View at Scopus
  16. T. F. Luscher, “Endothelin. Key to coronary vasospasm?” Circulation, vol. 83, no. 2, pp. 701–703, 1991. View at Google Scholar · View at Scopus
  17. G. Properzi, G. Terenghi, X. H. Gu et al., “Early increase precedes a depletion of endothelin-1 but not of von Willebrand factor in cutaneous microvessels of diabetic patients. A quantitative immunohistochemical study,” Journal of Pathology, vol. 175, no. 2, pp. 243–252, 1995. View at Publisher · View at Google Scholar · View at Scopus
  18. D. E. Kohan, “Endothelins in the normal and diseased kidney,” American Journal of Kidney Diseases, vol. 29, no. 1, pp. 2–26, 1997. View at Google Scholar · View at Scopus
  19. E. Anggard, S. Galton, G. Rae et al., “The fate of radioiodinated endothelin-1 and endothelin-3 in the rat,” Journal of Cardiovascular Pharmacology, vol. 13, no. 5, pp. S46–S49, 1989. View at Google Scholar · View at Scopus
  20. Z. A. Abassi, J. E. Tate, E. Golomb, and H. R. Keiser, “Role of neutral endopeptidase in the metabolism of endothelin,” Hypertension, vol. 20, no. 1, pp. 89–95, 1992. View at Google Scholar · View at Scopus
  21. C. Ihling, H. R. Göbel, A. Lippoldt et al., “Endothelin-1-like immunoreactivity in human atherosclerotic coronary tissue: a detailed analysis of the cellular distribution of endothelin-1,” Journal of Pathology, vol. 179, no. 3, pp. 303–308, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Ando, Y. Hirata, M. Shichiri, T. Emori, and F. Marumo, “Presence of immunoreactive endothelin in human plasma,” FEBS Letters, vol. 245, no. 1-2, pp. 164–166, 1989. View at Publisher · View at Google Scholar · View at Scopus
  23. M. V. Donoso, C. Salas, G. Sepulveda, J. Lewin, A. Fournier, and J. P. Huidobro-Toro, “Involvement of ETA receptors in the facilitation by endothelin-1 of non-adrenergic non-cholinergic transmission in the rat urinary bladder,” British Journal of Pharmacology, vol. 111, no. 2, pp. 473–482, 1994. View at Google Scholar · View at Scopus
  24. Y. Uchida, H. Ninomiya, M. Saotome et al., “Endothelin, a novel vasoconstrictor peptide, as potent bronchoconstrictor,” European Journal of Pharmacology, vol. 154, no. 2, pp. 227–228, 1988. View at Google Scholar · View at Scopus
  25. A. Bobik, A. Grooms, J. A. Millar, A. Mitchell, and S. Grinpukel, “Growth factor activity of endothelin on vascular smooth muscle,” American Journal of Physiology, vol. 258, no. 3, pp. C408–C415, 1990. View at Google Scholar · View at Scopus
  26. H. Syed, R. Safa, G. Chidlow, and N. N. Osborne, “Sulfisoxazole, an endothelin receptor antagonist, protects retinal neurones from insults of ischemia/reperfusion or lipopolysaccharide,” Neurochemistry International, vol. 48, no. 8, pp. 708–717, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Oku, M. Fukuhara, A. Komori, T. Okuno, T. Sugiyama, and T. Ikeda, “Endothelin-1 (ET-1) causes death of retinal neurons through activation of nitric oxide synthase (NOS) and production of superoxide anion,” Experimental Eye Research, vol. 86, no. 1, pp. 118–130, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Wollensak, H. E. Schaefer, and C. Ihling, “An immunohistochemical study of endothelin-1 in the human eye,” Current Eye Research, vol. 17, no. 5, pp. 541–545, 1998. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Takagi, P. S. Reinach, N. Yoshimura, and Y. Honda, “Endothelin-1 promotes corneal epithelial wound healing in rabbits,” Current Eye Research, vol. 13, no. 8, pp. 625–628, 1994. View at Google Scholar · View at Scopus
  30. E. L. Bek and M. A. McMillen, “Endothelins are angiogenic,” Journal of Cardiovascular Pharmacology, vol. 36, no. 5, pp. S135–S139, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. S. E. Bursell, A. C. Clermont, B. Oren, and G. L. King, “The in vivo effect of endothelins on retinal circulation in nondiabetic and diabetic rats,” Investigative Ophthalmology and Visual Science, vol. 36, no. 3, pp. 596–607, 1995. View at Google Scholar · View at Scopus
  32. K. Takahashi, M. A. Ghatei, H.-C. Lam, D. J. O'Halloran, and S. R. Bloom, “Elevated plasma endothelin in patients with diabetes mellitus,” Diabetologia, vol. 33, no. 5, pp. 306–310, 1990. View at Publisher · View at Google Scholar
  33. C. M. Bruno, S. Meli, M. Marcinno, D. Ierna, C. Sciacca, and S. Neri, “Plasma endothelin-1 levels and albumin excretion rate in normotensive, microalbuminuric type 2 diabetic patients,” Journal of Biological Regulators and Homeostatic Agents, vol. 16, no. 2, pp. 114–117, 2002. View at Google Scholar · View at Scopus
  34. F. P. Xu, M. S. Chen, Y. Z. Wang et al., “Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes,” Circulation, vol. 110, no. 10, pp. 1269–1275, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. W. Su, D.-Z. Dai, H.-R. Liu, T. Na, and Y. Dai, “Upregulated endothelin system in diabetic vascular dysfunction and early retinopathy is reversed by CPU0213 and total triterpene acids from Fructus Corni,” Clinical and Experimental Pharmacology and Physiology, vol. 34, no. 12, pp. 1228–1233, 2007. View at Publisher · View at Google Scholar
  36. Z. A. Khan, M. Cukiernik, J. R. Gonder, and S. Chakrabarti, “Oncofetal fibronectin in diabetic retinopathy,” Investigative Ophthalmology and Visual Science, vol. 45, no. 1, pp. 287–295, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. Z. A. Khan, H. Farhangkhoee, J. L. Mahon et al., “Endothelins: regulators of extracellular matrix protein production in diabetes,” Experimental Biology and Medicine, vol. 231, no. 6, pp. 1022–1029, 2006. View at Google Scholar · View at Scopus
  38. M. Golubovic-Arsovska, “Correlation of diabetic maculopathy and level of diabetic retinopathy,” Prilozi, vol. 27, no. 2, pp. 139–150, 2006. View at Google Scholar · View at Scopus
  39. L. Zheng, B. Gong, D. A. Hatala, and T. S. Kern, “Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes,” Investigative Ophthalmology and Visual Science, vol. 48, no. 1, pp. 361–367, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Makino, S. I. Oda, and K. Kamata, “Mechanisms underlying increased release of endothelin-1 from aorta in diabetic rats,” Peptides, vol. 22, no. 4, pp. 639–645, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. G. Mazzocchi, G. P. Rossi, L. K. Malendowicz, H. C. Champion, and G. G. Nussdorfer, “Endothelin-1[1–31], acting as an ETA-receptor selective agonist, stimulates proliferation of cultured rat zona glomerulosa cells,” FEBS Letters, vol. 487, no. 2, pp. 194–198, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. W. H. Herman and M. S. Simonson, “Nuclear signaling by endothelin-1. A Ras pathway for activation of the c-fos serum response element,” Journal of Biological Chemistry, vol. 270, no. 19, pp. 11654–11661, 1995. View at Publisher · View at Google Scholar · View at Scopus
  43. E. M. Vingolo, S. Lupo, P. L. Grenga et al., “Endothelin-1 plasma concentrations in patients with retinitis pigmentosa,” Regulatory Peptides, vol. 160, no. 1–3, pp. 64–67, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. D. T. Hartong, E. L. Berson, and T. P. Dryja, “Retinitis pigmentosa,” The Lancet, vol. 368, no. 9549, pp. 1795–1809, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. S. van Soest, A. Westerveld, P. T. V. M. de Jong, E. M. Bleeker-Wagemakers, and A. A. B. Bergen, “Retinitis pigmentosa: defined from a molecular point of view,” Survey of Ophthalmology, vol. 43, no. 4, pp. 321–334, 1999. View at Publisher · View at Google Scholar · View at Scopus
  46. A. W. Stitt, U. Chakravarthy, T. A. Gardiner, and D. B. Archer, “Endothelin-like immunoreactivity and receptor binding in the choroid and retina,” Current Eye Research, vol. 15, no. 1, pp. 111–117, 1996. View at Google Scholar · View at Scopus
  47. D. Y. Yu and S. J. Cringle, “Retinal degeneration and local oxygen metabolism,” Experimental Eye Research, vol. 80, no. 6, pp. 745–751, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Cellini, L. Santiago, P. Versura, and R. Caramazza, “Plasma levels of endothelin-1 in retinitis pigmentosa,” Ophthalmologica, vol. 216, no. 4, pp. 265–268, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. E. M. Vingolo, M. Rocco, P. L. Grenga, S. Salvatore, and P. Pelaia, “Slowing the degenerative process, long lasting effect of hyperbaric oxygen therapy in retinitis pigmentosa,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 246, no. 1, pp. 93–98, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. B. C. Chauhan, “Endothelin and its potential role in glaucoma,” Canadian Journal of Ophthalmology, vol. 43, no. 3, pp. 356–360, 2008. View at Publisher · View at Google Scholar
  51. S. Orgül, G. A. Cioffi, D. J. Wilson, D. R. Bacon, and E. M. van Buskirk, “An endothelin-1 induced model of optic nerve ischemia in the rabbit,” Investigative Ophthalmology and Visual Science, vol. 37, no. 9, pp. 1860–1869, 1996. View at Google Scholar · View at Scopus
  52. M. Emre, S. Orgül, T. Haufschild, S. G. Shaw, and J. Flammer, “Increased plasma endothelin-1 levels in patients with progressive open angle glaucoma,” British Journal of Ophthalmology, vol. 89, no. 1, pp. 60–63, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Heijl, M. C. Leske, B. Bengtsson, L. Hyman, B. Bengtsson, and M. Hussein, “Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial,” Archives of Ophthalmology, vol. 120, no. 10, pp. 1268–1279, 2002. View at Google Scholar · View at Scopus
  54. D. R. Anderson, “What happens to the optic disc and retina in glaucoma?” Ophthalmology, vol. 90, no. 7, pp. 766–770, 1983. View at Google Scholar · View at Scopus
  55. J. Sharkey, I. M. Ritchie, and P. A. T. Kelly, “Perivascular microapplication of endothelin-1: a new model of focal cerebral ischaemia in the rat,” Journal of Cerebral Blood Flow and Metabolism, vol. 13, no. 5, pp. 865–871, 1993. View at Google Scholar
  56. E. Hartter and W. Woloszczuk, “Radioimmunoassay of endothelin,” The Lancet, vol. 1, no. 8643, p. 909, 1989. View at Google Scholar · View at Scopus
  57. I. Ziv, G. Fleminger, R. Djaldetti, A. Achiron, E. Melamed, and M. Sokolovsky, “Increased plasma endothelin-1 in acute ischemic stroke,” Stroke, vol. 23, no. 7, pp. 1014–1016, 1992. View at Google Scholar · View at Scopus
  58. K. Nishimura, C. E. Riva, S. Harino, P. Reinach, S. D. Cranstoun, and S. Mita, “Effects of endothelin-1 on optic nerve head blood flow in cats,” Journal of Ocular Pharmacology and Therapeutics, vol. 12, no. 1, pp. 75–83, 1996. View at Google Scholar · View at Scopus
  59. L. Schmetterer, O. Findl, K. Strenn et al., “Effects of endothelin-1 (ET-1) on ocular hemodynamics,” Current Eye Research, vol. 16, no. 7, pp. 687–692, 1997. View at Publisher · View at Google Scholar · View at Scopus
  60. T. Sugiyama, S. Moriya, H. Oku, and I. Azuma, “Association of endothelin-1 with normal tension glaucoma: clinical and fundamental studies,” Survey of Ophthalmology, vol. 39, no. 1, pp. S49–S56, 1995. View at Google Scholar · View at Scopus
  61. H. J. Kaiser, J. Flammer, M. Wenk, and T. Luscher, “Endothelin-1 plasma levels in normal-tension glaucoma: abnormal response to postural changes,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 233, no. 8, pp. 484–488, 1995. View at Google Scholar · View at Scopus
  62. W. Noske, “Endothelin-like immunoreactivity in aqueous humor of patients with primary open-angle glaucoma and cataract,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 235, no. 9, pp. 551–552, 1997. View at Publisher · View at Google Scholar
  63. A. Nagata, H. Mishima, K. Choshi, S. Shimada, and Y. Furumoto, “Fluorescein fundus angiography of optic nerve head in primary open angle glaucoma and low tension glaucoma,” Nippon Ganka Gakkai Zasshi, vol. 96, no. 11, pp. 1423–1428, 1992. View at Google Scholar
  64. G. A. Cioffi, “Ischemic model of optic nerve injury,” Transactions of the American Ophthalmological Society, vol. 103, pp. 592–613, 2005. View at Google Scholar · View at Scopus
  65. A. Ripodas, J. A. de Juan, M. Roldán-Pallarés et al., “Localisation of endothelin-1 mRNA expression and immunoreactivity in the retina and optic nerve from human and porcine eye. Evidence for endothelin-1 expression in astrocytes,” Brain Research, vol. 912, no. 2, pp. 137–143, 2001. View at Publisher · View at Google Scholar
  66. M. W. MacCumber and S. A. D'Anna, “Endothelin receptor-binding subtypes in the human retina and choroid,” Archives of Ophthalmology, vol. 112, no. 9, pp. 1231–1235, 1994. View at Google Scholar · View at Scopus
  67. M. Roldán-Pallarés, R. Rollín, R. Bernal et al., “Proliferative vitreoretinopathy: immunoreactive endothelin-1,” Annals of Ophthalmology, vol. 36, no. 1, pp. 24–28, 2004. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Roldán-Pallarés, R. Rollín, A. Mediero et al., “Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy,” Molecular Vision, vol. 11, pp. 461–471, 2005. View at Google Scholar · View at Scopus
  69. M. N. Delyfer, V. Forster, N. Neveux, S. Picaud, T. Léveillard, and J. A. Sahel, “Evidence for glutamate-mediated excitotoxic mechanisms during photoreceptor degeneration in the rd1 mouse retina,” Molecular Vision, vol. 11, pp. 688–696, 2005. View at Google Scholar · View at Scopus
  70. S. Narayan, A. M. Brun, and T. Yorio, “Endothelin-1 distribution and basolateral secretion in the retinal pigment epithelium,” Experimental Eye Research, vol. 79, no. 1, pp. 11–19, 2004. View at Publisher · View at Google Scholar · View at Scopus
  71. M. W. MacCumber, C. A. Ross, and S. H. Snyder, “Endothelin in brain: receptors, mitogenesis, and biosynthesis in Glial cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 6, pp. 2359–2363, 1990. View at Google Scholar · View at Scopus
  72. X. J. Nie and Y. Olsson, “Endothelin peptides in brain diseases,” Reviews in the Neurosciences, vol. 7, no. 3, pp. 177–186, 1996. View at Google Scholar · View at Scopus
  73. Y. Sasaki, M. Takimoto, K. Oda et al., “Endothelin evokes efflux of glutamate in cultures of rat astrocytes,” Journal of Neurochemistry, vol. 68, no. 5, pp. 2194–2200, 1997. View at Google Scholar · View at Scopus
  74. Y. Koyama, M. Takemura, K. Fujiki, N. Ishikawa, Y. Shigenaga, and A. Baba, “BQ788, an endothelin ET(B) receptor antagonist, attenuates stab wound injury-induced reactive astrocytes in rat brain,” Glia, vol. 26, no. 3, pp. 268–271, 1999. View at Publisher · View at Google Scholar · View at Scopus
  75. M. Hasselblatt, P. Lewczuk, B. M. Löffler et al., “Role of the astrocytic ET receptor in the regulation of extracellular endothelin-1 during hypoxia,” Glia, vol. 34, no. 1, pp. 18–26, 2001. View at Publisher · View at Google Scholar · View at Scopus
  76. S. D. Rogers, C. M. Peters, J. D. Pomonis, H. Hagiwara, J. R. Ghilardi, and P. W. Mantyh, “Endothelin B receptors are expressed by astrocytes and regulate astrocyte hypertrophy in the normal and injured CNS,” Glia, vol. 41, no. 2, pp. 180–190, 2003. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Roldán-Pallarés, A. Sadiq-Musa, R. Rollin, C. Bravo-Llatas, A. Fernández-Cruz, and R. Fernández-Durango, “Retinal detachment: visual acuity and subretinal immunoreactive endothelin-1,” Journal Francais d'Ophtalmologie, vol. 31, no. 1, pp. 36–41, 2008. View at Publisher · View at Google Scholar · View at Scopus
  78. M. E. Stokely, T. Yorio, and M. A. King, “Endothelin-1 modulates anterograde fast axonal transport in the central nervous system,” Journal of Neuroscience Research, vol. 79, no. 5, pp. 598–607, 2005. View at Publisher · View at Google Scholar · View at Scopus
  79. V. Torbidoni, M. Iribarne, and A. M. Suburo, “Endothelin receptors in light-induced retinal degeneration,” Experimental Biology and Medicine, vol. 231, no. 6, pp. 1095–1100, 2006. View at Google Scholar · View at Scopus
  80. R. Scorza, A. Santaniello, G. Salazar et al., “Aminaftone, a derivative of 4-aminobenzoic acid, downregulates endothelin-1 production in ECV304 cells: an in vitro study,” Drugs in R&D, vol. 9, no. 4, pp. 251–257, 2008. View at Publisher · View at Google Scholar · View at Scopus